Anemia in Heart Failure: A Perspective from 20-Year Bibliometric Analysis
Qiwen Yang,Tairan Dong,Diyang Lyu,Donghua Xue,Rui Zhuang,Liyong Ma,Lijing Zhang
DOI: https://doi.org/10.2147/ijgm.s456558
IF: 2.145
2024-05-03
International Journal of General Medicine
Abstract:Qiwen Yang, 1, 2, &ast Tairan Dong, 1, &ast Diyang Lyu, 2 Donghua Xue, 1, 2 Rui Zhuang, 2 Liyong Ma, 2 Lijing Zhang 2 1 Graduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China; 2 Department of Cardiology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lijing Zhang, Department of Cardiology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China, Email Background & Objective: Anemia in patients with heart failure (HF) is a growing concern. However, there has no bibliometric analysis in this area up to now. The aim of this study is to explore the status and trends in the field of anemia in HF through the bibliometric analysis, and to provide an outlook on future research. Methods: We retrieved publications from the Web of Science Core Collection database, and the following data analysis and visualization tools were utilized to perform data processing, statistical computing and graphics generation: VOSviewer (v.1.6.18), CiteSpace (v.6.2 R5), Scimago Graphica (v.1.0.36), Biblimatrix and Microsoft Excel. Results: We identified a total of 3490 publications from 2004 to 2023. The publications in the field of anemia in HF are growing steadily. The United States, the United Kingdom, and Italy were the leading countries in this area. Stefan D Anker, as the most influential author, held the most total citations and publications. Harvard University was the most productive institution in this area. The European Journal of Heart Failure had published the most papers. Through the analysis of co-citations, 14 major clusters based on cluster labels were identified. Keyword analysis showed that mortality, outcome, prevalence, and risk were the most frequent keywords, and the potential research hotspots in the future will be intravenous iron and iron deficiency. Conclusion: This study provides a comprehensive analysis of countries, authors, institutions, journals, co-cited references, and keywords in the field of anemia in HF through bibliometric analysis and data visualization. The status, hotspots and future trends in this field offer a reference for in-depth research. Further studies are necessary in the future to broaden the spectrum of research in this field, to evaluate comprehensive approaches to treating anemia in patients with HF, and to find rational targets for the management of anemia. Keywords: anemia, heart failure, hemoglobin, iron deficiency, bibliometrics Heart failure (HF) is a common clinical syndrome that can be caused by a variety of cardiac diseases and often identified by characteristic symptoms such as fatigue and dyspnea caused by structural or functional defects in ventricular filling or ejection of blood. 1–4 It is estimated that about 64 million people worldwide suffer from heart failure. 5 Due to the fact that most clinical studies include only confirmed cases of HF, the true prevalence is likely to be higher. 6 The clinical burden of HF includes impaired quality of life, 4,7 high rates of hospitalization, 8,9 and poor prognosis. 10,11 Considering the current state of HF, its prevention and management has become a formidable task. Anemia is also a global public health concern 12,13 with a significant impact on both morbidity and mortality. 4,14,15 It is defined by the World Health Organization (WHO) as a serum hemoglobin level of less than 13 g/dL for adult males and less than 12 g/dL for adult females. 16 The WHO criteria are widely used to define anemia in HF patients. 4,17,18 It is estimated that the prevalence of anemia is 17% in patients with new-onset HF and ≈30% in stable and ≈50% in hospitalized HF patients. 18,19 Unfortunately, this is a more serious problem for developing countries. Compared to in Sweden, HF patients in Tanzania have more frequent anemia (57% vs 9%). 20 And in Egypt, the prevalence of anemia in non-hospitalized HF patients is up to 62.9%. 21 Reduced hemoglobin concentration leads to impaired oxygen-carrying capacity of the blood, and anemia may lead to exercise intolerance when compensations of the cardiovascular and skeletal muscle systems are exceeded. This generally happens only for severe anemia but may happen for a lesser degree of anemia in patients with HF. 22 As a consequence, compared with patients with normal hemoglobin, anemic HF patients have lower peak oxygen consumption (peak VO2) 23</ -Abstract Truncated-
medicine, general & internal